Clinical and Diagnostic Laboratory Immunology, 05 1994, 304-309, Vol 1, No. 3
Copyright © 1994 by the American Society for Microbiology. All rights reserved.

T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis

AM Cooper, PC Melby, CL Karp, F Neva and DL Sacks
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, Bethesda, Maryland 20892, USA.

Although there is strong evidence that the control and resolution of human leishmanial infections depend primarily on activation of parasite- infected macrophages mediated by lymphokines derived from T cells, less is known about the nature of the responding cell type(s) which is protective or the antigen(s) (Ag[s]) that elicits these cells to respond. Studies using preparations of whole soluble Ag ("dead Ag") show that patients respond to a wide range of leishmanial Ags. The objective of the present study was to characterize the response of T cells from patients with healing or healed cutaneous or mucosal infections to Ag expressed by or derived from actively infected autologous monocytes ("live Ag"). Unfractionated T cells proliferated and produced gamma interferon in response to both live and dead Ags. Depletion of CD4+ T cells resulted in the loss of proliferative and gamma interferon responses to both live and dead Ags. The effect of CD8 depletion, although variable and not limited to the cells stimulated by infected monocytes, was clear for some patients. Expansion of T cells specific for live Ags by using amastigote-infected cells followed by restimulation with fast-protein liquid chromatography-fractionated soluble Ags revealed that a diversity of Ags are associated with infected monocytes. There may, however, be quantitative differences in the expression of certain Ags since prestimulation with live Ag induced higher responses to restimulation in mucocutaneous leishmaniasis patients than in localized cutaneous leishmaniasis patients. Prestimulation with dead Ag induced similar secondary responses in both patient groups.